ASX:COHMedical Equipment
How Cochlear’s FY26 Profit Downgrade Will Impact Cochlear (ASX:COH) Investors
In the past few days, Cochlear Limited cut its FY26 underlying net profit guidance to A$290 million–A$330 million, citing weaker implant demand in developed markets, Middle East delivery and receivables risk, margin pressure, and higher restructuring costs.
This guidance downgrade highlights how operational challenges in key geographies and rising costs can alter expectations for a business often viewed as a core ASX healthcare exposure.
We’ll now examine how Cochlear’s reduced FY26 profit...